The distribution and pathogenic risk of non‐9‐valent vaccine covered HPV subtypes in cervical lesions-Reference-Cited by-同舟云学术

The distribution and pathogenic risk of non‐9‐valent vaccine covered HPV subtypes in cervical lesions

Published:2022-01-03 Issue:6 Volume:11 Page:1542-1552
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Medicine

Author:

Ma Mingjun¹,Zhu Jingfen²,Yang Yongbin¹,Wang Xiaoyun¹,Jin Yubiao³,Zhang Jiawen¹⁴^ORCID,Wu Sufang¹

Affiliation:

1. Department of Obstetrics and Gynecology Shanghai General Hospital School of Medicine Shanghai Jiao Tong University Shanghai P.R. China

2. School of Public Health Shanghai Jiao Tong University Shanghai P.R. China

3. Department of Pathology Shanghai General Hospital School of Medicine Shanghai Jiao Tong University Shanghai P.R. China

4. Reproductive Medicine Center Department of Obstetrics and Gynecology Shanghai General Hospital School of Medicine Shanghai Jiao Tong University Shanghai P.R. China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.4532

Reference34 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. The epidemiology of human papillomavirus infections

3. HPV - immune response to infection and vaccination

4. Human papillomavirus vaccines. WHO position paper;Releve Epidemiologique Hebdomadaire,2009

5. Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 7-year follow-up of the phase 3, double-blind, randomised controlled VIVIANE study

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevalence and genotype distribution of HPV combined with cervical pathological results in women from Sichuan, China: A cross‐sectional study based on post‐vaccination period 2019 to 2023;Cancer Medicine;2024-08

2. Distribution of HPV types among women with HPV-related diseases and exploration of lineages and variants of HPV 52 and 58 among HPV-infected patients in China: A systematic literature review;Human Vaccines & Immunotherapeutics;2024-05-14

3. Investigation of Human Papillomavirus (HPV) Frequency and Genotype Analysis in Cervical Samples;Journal of Biotechnology and Strategic Health Research;2024-04-30

4. Characteristic of persistent human papillomavirus infection in women worldwide: a meta–analysis;PeerJ;2023-11-14